Peritoneal Metastases Clinical Trials
2 recruiting trials for Peritoneal Metastases. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Peritoneal Metastases clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Yale University (1), Chinese Academy of Sciences (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Mass-based response testing (MRT) (device, 1 trial), followed by Peritoneal metastasis status ascertainment.
Track Peritoneal Metastases trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal...
This study will evaluate the role of mass-based response testing (MRT) to select and deliver personalized hyperthermic intraperitoneal chemotherapy (HIPEC) regimens to patients...
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Peritoneal metastasis of gastric cancer is difficult to be detected in time, thus delaying treatment. Based on the conventional CT images of gastric cancer, this study plans to...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Peritoneal Metastases, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Peritoneal Metastases, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Peritoneal Metastases, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.